| Literature DB >> 32424362 |
Sandip Mukherjee1,2, Ritesh Kumar1,2, Elviche Tsakem Lenou1,2, Venkatesha Basrur3, Dimitris L Kontoyiannis4,5, Fotis Ioakeimidis5, George Mosialos4, Arianne L Theiss6, Richard A Flavell7, K Venuprasad8,9.
Abstract
The inflammasome NLRP6 plays a crucial role in regulating inflammation and host defense against microorganisms in the intestine. However, the molecular mechanisms by which NLRP6 function is inhibited to prevent excessive inflammation remain unclear. Here, we demonstrate that the deubiquitinase Cyld prevents excessive interleukin 18 (IL-18) production in the colonic mucosa by deubiquitinating NLRP6. We show that deubiquitination inhibited the NLRP6-ASC inflammasome complex and regulated the maturation of IL-18. Cyld deficiency in mice resulted in elevated levels of active IL-18 and severe colonic inflammation following Citrobacter rodentium infection. Further, in patients with ulcerative colitis, the concentration of active IL-18 was inversely correlated with CYLD expression. Thus, we have identified a novel regulatory mechanism that inhibits the NLRP6-IL-18 pathway in intestinal inflammation.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32424362 PMCID: PMC7881443 DOI: 10.1038/s41590-020-0681-x
Source DB: PubMed Journal: Nat Immunol ISSN: 1529-2908 Impact factor: 25.606